SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Belanger who wrote (1035)6/24/1997 1:32:00 PM
From: Howard Hoffman   of 1762
 
Yes. We'll see. Someone really bailed out already today, with IDPH trading as low as 21. On the other hand, the stock, now around 23 1/2, is well above the levels of May.

The real action for IDPH will be when C2B8 is approved, although the RA business seems to have been dealt a major setback.

If SmithKline was selling a month ago, perhaps they wanted to be sure that they were not accused of selling right at the peak price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News